Spero Therapeutics, Inc.: Form 8-K/A, filed Oct 16, 2023
Filed with the SEC on Oct 16, 2023 and accepted by EDGAR at Oct 16, 2023, 16:01 ET.
Items reported
- Item 5.03 Amendment to articles or bylaws
- Item 5.07 Shareholder vote results
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-23-256865. Last ingested by Listed: Oct 29, 2026, 04:34 ET. Listed shows no prices and gives no investment advice.